Morpholino

MO1-larp7

ID

ZDB-MRPHLNO-090911-3

Name

MO1-larp7

Previous Names

None

Target

Sequence

5' - ATTAATAAAGTTACATACATCCATC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-larp7

No data available

Phenotype

Phenotype resulting from MO1-larp7

Phenotype	Fish	Figures
animal organ development disrupted, abnormal	WT + MO1-larp7	Fig. 5 from Barboric et al., 2009
brain degenerate, abnormal	WT + MO1-larp7	Fig. 5 from Barboric et al., 2009
embryo development disrupted, abnormal	WT + MO1-larp7	Fig. 5 from Barboric et al., 2009

Phenotype of all Fish created by or utilizing MO1-larp7

Phenotype	Fish	Conditions	Figures
neural crest mitfa expression amount, ameliorated	WT + MO1-larp7	chemical treatment: leflunomide	Fig. S3 from Tan et al., 2016
animal organ development disrupted, abnormal	WT + MO1-larp7	standard conditions	Fig. 5 from Barboric et al., 2009
embryo development disrupted, abnormal	WT + MO1-larp7	standard conditions	Fig. 5 from Barboric et al., 2009
neural crest crestin expression amount, ameliorated	WT + MO1-larp7	chemical treatment: leflunomide	Fig. S3 from Tan et al., 2016
brain degenerate, abnormal	WT + MO1-larp7	standard conditions	Fig. 5 from Barboric et al., 2009
melanocyte amount, ameliorated	WT + MO1-larp7	chemical treatment: leflunomide	Fig. S3 from Tan et al., 2016

Citations